{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:53:39Z","timestamp":1790146419069,"version":"4.0.1"},"reference-count":48,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,25]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>In unmanipulated haplo-HSCT, antigenic HLA-DRB1 match, stem cell source, conditioning, and donor sex are associated with GVHD. The role of HLA-matching status and other factors influencing alloreactivity is more prominent with PTCy compared to ATG GVHD prophylaxis.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017006429","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T20:40:27Z","timestamp":1492807227000},"page":"669-680","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":54,"title":["The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis"],"prefix":"10.1182","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3596-9810","authenticated-orcid":false,"given":"Francesca","family":"Lorentino","sequence":"first","affiliation":[{"name":"Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Labopin","sequence":"additional","affiliation":[{"name":"H\u00e9matologie Clinique et Th\u00e9rapie Cellulaire, H\u00f4pital Saint-Antoine, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France;"},{"name":"Universit\u00e8 Pierre et Marie Curie, Paris, France;"},{"name":"Unit\u00e9 de Recherche Mixte en Sant\u00e9 (UMR_S) 938, INSERM, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Fleischhauer","sequence":"additional","affiliation":[{"name":"Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlheinz R.","family":"Mueller","sequence":"additional","affiliation":[{"name":"German National Bone Marrow Donor Registry, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Ruggeri","sequence":"additional","affiliation":[{"name":"H\u00e9matologie Clinique et Th\u00e9rapie Cellulaire, H\u00f4pital Saint-Antoine, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France;"},{"name":"Universit\u00e8 Pierre et Marie Curie, Paris, France;"},{"name":"Unit\u00e9 de Recherche Mixte en Sant\u00e9 (UMR_S) 938, INSERM, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avichai","family":"Shimoni","sequence":"additional","affiliation":[{"name":"Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[{"name":"Medizinische Klinik Und Poliklinik I, Universit\u00e4tsklinikum Carl Gustav Carus Der Technische Universit\u00e4t Dresden, Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bacigalupo","sequence":"additional","affiliation":[{"name":"Division of Hematology, Catholic University of the Sacred Heart, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafer","family":"G\u00fclbas","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Department, Anadolu Medical Center Hospital, Kocaeli, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yener","family":"Koc","sequence":"additional","affiliation":[{"name":"Hematopoietic Stem Cell Transplantation Unit, Medical Park Hospital, Antalya, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Arcese","sequence":"additional","affiliation":[{"name":"Stem Cell Transplant Unit, Fondazione Policlinico Tor Vergata, Tor Vergata University, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Bruno","sequence":"additional","affiliation":[{"name":"Dipartimento di Ematologia, Presidio Molinette, Universit\u00e1 di Torino, Turin, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Tischer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Hematopoietic Cell Transplantation, Grosshadern Clinic, University Hospital of Munich (Ludwig Maximilians University), Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Blaise","sequence":"additional","affiliation":[{"name":"Programme de Transplantation et Th\u00e9rapie Cellulaire, Centre de Recherche en Canc\u00e9rologie de Marseille, Institut Paoli Calmettes, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Messina","sequence":"additional","affiliation":[{"name":"Hematology and Stem Transplantation Unit, Onco-Hematology Department, Bianchi Melacrino Morelli Hospital Agency, Reggio Calabria, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich W.","family":"Beelen","sequence":"additional","affiliation":[{"name":"Department of Bone Marrow Transplantation, University Hospital, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[{"name":"Universit\u00e8 Pierre et Marie Curie, Paris, France;"},{"name":"Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[{"name":"H\u00e9matologie Clinique et Th\u00e9rapie Cellulaire, H\u00f4pital Saint-Antoine, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France;"},{"name":"Universit\u00e8 Pierre et Marie Curie, Paris, France;"},{"name":"Unit\u00e9 de Recherche Mixte en Sant\u00e9 (UMR_S) 938, INSERM, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2017,4,21]]},"reference":[{"issue":"2","key":"2019111607443285100_B1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00000441-198708000-00003","article-title":"Marrow transplantation for malignant disease","volume":"294","author":"Thomas","year":"1987","journal-title":"Am J Med Sci"},{"issue":"16","key":"2019111607443285100_B2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM197504172921605","article-title":"Bone-marrow transplantation (first of two parts)","volume":"292","author":"Thomas","year":"1975","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111607443285100_B3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM198901263200401","article-title":"Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma","volume":"320","author":"Anasetti","year":"1989","journal-title":"N Engl J Med"},{"issue":"13","key":"2019111607443285100_B4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM198509263131301","article-title":"Marrow transplantation from related donors other than HLA-identical siblings","volume":"313","author":"Beatty","year":"1985","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111607443285100_B5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bbmt.2007.04.010","article-title":"HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival","volume":"13","author":"Loiseau","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"2019111607443285100_B6","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"issue":"suppl 1","key":"2019111607443285100_B7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1399-0039.2006.759_2.x","article-title":"Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors","volume":"69","author":"Petersdorf","year":"2007","journal-title":"Tissue Antigens"},{"issue":"9577","key":"2019111607443285100_B8","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)60915-5","article-title":"Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study","volume":"369","author":"Eapen","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"2019111607443285100_B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbmt.2007.11.003","article-title":"State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants","volume":"14","author":"Kamani","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2019111607443285100_B10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.exphem.2004.01.002","article-title":"Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice","volume":"32","author":"Gluckman","year":"2004","journal-title":"Exp Hematol"},{"issue":"7","key":"2019111607443285100_B11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1182\/blood-2014-10-604785","article-title":"Biological significance of HLA locus matching in unrelated donor bone marrow transplantation","volume":"125","author":"Morishima","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2019111607443285100_B12","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2004-03-0803","article-title":"Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome","volume":"104","author":"Flomenberg","year":"2004","journal-title":"Blood"},{"issue":"5","key":"2019111607443285100_B13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.coi.2008.06.014","article-title":"Optimal HLA matching in hematopoietic cell transplantation","volume":"20","author":"Petersdorf","year":"2008","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"2019111607443285100_B14","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1182\/blood.V99.11.4200","article-title":"The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors","volume":"99","author":"Morishima","year":"2002","journal-title":"Blood"},{"issue":"6","key":"2019111607443285100_B15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbmt.2010.09.012","article-title":"HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation","volume":"17","author":"Woolfrey","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111607443285100_B16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood.V81.1.249.249","article-title":"Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus","volume":"81","author":"Beatty","year":"1993","journal-title":"Blood"},{"issue":"10","key":"2019111607443285100_B17","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1182\/blood.V92.10.3515","article-title":"Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient","volume":"92","author":"Petersdorf","year":"1998","journal-title":"Blood"},{"issue":"13","key":"2019111607443285100_B18","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S1470-2045(11)70260-1","article-title":"Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis","volume":"12","author":"Eapen","year":"2011","journal-title":"Lancet Oncol"},{"issue":"12","key":"2019111607443285100_B19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.bmt.1705189","article-title":"High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood\/patient pair transplants hardly improves long-term clinical outcome","volume":"36","author":"K\u00f6gler","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2019111607443285100_B20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/leu.2014.336","article-title":"A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia","volume":"29","author":"Piemontese","year":"2015","journal-title":"Leukemia"},{"issue":"5","key":"2019111607443285100_B21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/cncr.27761","article-title":"Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center","volume":"119","author":"Wang","year":"2013","journal-title":"Cancer"},{"issue":"5","key":"2019111607443285100_B22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood-2012-08-453399","article-title":"Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies","volume":"121","author":"Di Bartolomeo","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2019111607443285100_B23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/leu.2014.180","article-title":"Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors","volume":"29","author":"Peccatori","year":"2015","journal-title":"Leukemia"},{"issue":"6","key":"2019111607443285100_B24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl 2","key":"2019111607443285100_B25","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1038\/bmt.2015.93","article-title":"Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update","volume":"50","author":"Bacigalupo","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2019111607443285100_B26","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.bbmt.2015.04.025","article-title":"Post-transplantation cyclophosphamide and sirolimus after haploidentical hematopoietic stem cell transplantation using a treosulfan-based myeloablative conditioning and peripheral blood stem cells","volume":"21","author":"Cieri","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2019111607443285100_B27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3324\/haematol.2016.151779","article-title":"Post-transplant cyclophosphamide versus anti-thymocyte-globulin as graft- versus-host disease prophylaxis in haploidentical transplant","volume":"102","author":"Ruggeri","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"2019111607443285100_B28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbmt.2009.11.011","article-title":"Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome","volume":"16","author":"Kasamon","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2019111607443285100_B29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1399-0012.2011.01499.x","article-title":"The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation","volume":"26","author":"Huo","year":"2012","journal-title":"Clin Transplant"},{"issue":"6","key":"2019111607443285100_B30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","article-title":"Who is the best donor for a related HLA haplotype-mismatched transplant?","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2019111607443285100_B31","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2010.79","article-title":"An update to HLA nomenclature, 2010","volume":"45","author":"Marsh","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2019111607443285100_B32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.humimm.2016.05.002","article-title":"Charting improvements in US Registry HLA typing ambiguity using a typing resolution score","volume":"77","author":"Pauni","year":"2016","journal-title":"Hum Immunol"},{"issue":"12","key":"2019111607443285100_B33","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.humimm.2007.10.009","article-title":"Estimation of HLA-A, -B, -DRB1 haplotype frequencies using mixed resolution data from a national registry with selective retyping of volunteers","volume":"68","author":"Kollman","year":"2007","journal-title":"Hum Immunol"},{"issue":"4","key":"2019111607443285100_B34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"4","key":"2019111607443285100_B35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"2019111607443285100_B36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"6","key":"2019111607443285100_B37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"issue":"3","key":"2019111607443285100_B38","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"2019111607443285100_B39","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"2","key":"2019111607443285100_B40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B"},{"issue":"5","key":"2019111607443285100_B41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJMoa0811036","article-title":"Loss of mismatched HLA in leukemia after stem-cell transplantation","volume":"361","author":"Vago","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111607443285100_B42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(12)70004-9","article-title":"Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study","volume":"13","author":"Fleischhauer","year":"2012","journal-title":"Lancet Oncol"},{"issue":"7","key":"2019111607443285100_B43","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1182\/blood-2009-01-200378","article-title":"Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation","volume":"114","author":"Crocchiolo","year":"2009","journal-title":"Blood"},{"issue":"16","key":"2019111607443285100_B44","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2014-05-576041","article-title":"Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation","volume":"124","author":"Pidala","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2019111607443285100_B45","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V99.5.1572","article-title":"Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling","volume":"99","author":"van Rood","year":"2002","journal-title":"Blood"},{"issue":"6","key":"2019111607443285100_B46","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bmt.2016.20","article-title":"Hematopoietic stem cell transplantation in Europe 2014: more than 40\u2009000 transplants annually","volume":"51","author":"Passweg","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111607443285100_B47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood"},{"issue":"26","key":"2019111607443285100_B48","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1182\/blood-2015-02-580043","article-title":"Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine","volume":"125","author":"Hunger","year":"2015","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/11\/669\/877101\/advances006429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/11\/669\/877101\/advances006429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T14:29:46Z","timestamp":1719152986000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/11\/669\/15634\/The-impact-of-HLA-matching-on-outcomes-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,21]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,4,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017006429","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,21]]}}}